In today’s briefing:
- Blood, Sweat, and Bids: Grifols Draws Renewed Interest from Brookfield
- SBC: Recent Growth Measures Include Multi-Brand Strategy
Blood, Sweat, and Bids: Grifols Draws Renewed Interest from Brookfield
- Brookfield has renewed takeover interest in Grifols after a failed bid, signaling confidence in the company’s turnaround and prompting investor speculation about a significantly improved future offer.
- Grifols’ financial position has strengthened with a 4.6x Net Debt/EBITDA, €504 million in free cash flow, and strategic refinancing, reducing the likelihood of a capital increase and supporting shareholder value.
- Grifols B shares trade at a 21.6% discount to A shares, offering an attractive convergence opportunity, as bylaws mandate equal treatment in the event of a public acquisition offer.
SBC: Recent Growth Measures Include Multi-Brand Strategy
- Among other growth measures SBC intends to add new services, often leveraging a multi-branding strategy to broaden its target market and retain strategic pricing power as it targets new demographics – some from rising medical tourism – & enhance its outreach by increasing social media marketing.
- The company believes its strong market position & financial position ($125m in cash at YE24) can enable it to successfully expand its footprint domestically, internationally and into new services.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
